Publication|Articles|July 8, 2024
Supplements and Featured Publications
- Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Advertisement
This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
4
How Effective and Safe Are GLP-1s for Weight Loss?
5










































